The head of preclinical development at Imbrium Therapeutics provided an overview of positive safe and efficacy findings from the phase 2 study investigating sunobinop. [WATCH TIME: 4 minutes]
Garth T. Whiteside, PhD
Advertisement
Head of preclinical development at Imbrium Therapeutics
Articles by Garth T. Whiteside, PhD
Advertisement
Latest Updated Articles
Sleep Disturbances and Recovering From Alcohol Use Disorder: Garth T. Whiteside, PhDPublished: February 13th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Paraneoplastic Neurologic Syndromes Present Before Testicular Germ Cell Tumor Diagnosis, Study Shows
2
This Week on NeurologyLive® — October 27, 2025
3
Enhancing Stroke Systems of Care
4
NeurologyLive® Brain Games: October 26, 2025
5
